High materiality8/10
H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wainwright reiterates Buy; target $25; current price $12.11.
- Target $25; price $12.11.
Key facts
- 01
Target: $25
- 02
Posted price: $12.11
- 03
Analyst firm: New Street
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.